China
· Delayed Price · Currency is CNY Yifeng Pharmacy Chain Statistics
Total Valuation
Yifeng Pharmacy Chain has a market cap or net worth of CNY 30.06 billion. The enterprise value is 28.20 billion.
| Market Cap | 30.06B |
| Enterprise Value | 28.20B |
Important Dates
The next estimated earnings date is Tuesday, April 29, 2025.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | Oct 15, 2024 |
Share Statistics
Yifeng Pharmacy Chain has 1.21 billion shares outstanding. The number of shares has increased by 1.00% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.21B |
| Shares Change (YoY) | +1.00% |
| Shares Change (QoQ) | +0.58% |
| Owned by Insiders (%) | 11.85% |
| Owned by Institutions (%) | 20.32% |
| Float | 555.39M |
Valuation Ratios
The trailing PE ratio is 19.73 and the forward PE ratio is 18.53. Yifeng Pharmacy Chain's PEG ratio is 1.45.
| PE Ratio | 19.73 |
| Forward PE | 18.53 |
| PS Ratio | 1.26 |
| PB Ratio | 2.93 |
| P/TBV Ratio | 6.01 |
| P/FCF Ratio | 7.01 |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.45 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.44, with an EV/FCF ratio of 6.58.
| EV / Earnings | 18.51 |
| EV / Sales | 1.18 |
| EV / EBITDA | 7.44 |
| EV / EBIT | 13.09 |
| EV / FCF | 6.58 |
Financial Position
The company has a current ratio of 1.19, with a Debt / Equity ratio of 0.51.
| Current Ratio | 1.19 |
| Quick Ratio | 0.83 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | 1.46 |
| Debt / FCF | 1.29 |
| Interest Coverage | 10.89 |
Financial Efficiency
Return on equity (ROE) is 15.79% and return on invested capital (ROIC) is 8.96%.
| Return on Equity (ROE) | 15.79% |
| Return on Assets (ROA) | 5.48% |
| Return on Capital (ROIC) | 8.96% |
| Revenue Per Employee | 603,225 |
| Profits Per Employee | 38,417 |
| Employee Count | 39,652 |
| Asset Turnover | 0.97 |
| Inventory Turnover | 3.99 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.32% in the last 52 weeks. The beta is 0.27, so Yifeng Pharmacy Chain's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -20.32% |
| 50-Day Moving Average | 24.53 |
| 200-Day Moving Average | 27.15 |
| Relative Strength Index (RSI) | 51.71 |
| Average Volume (20 Days) | 8,853,465 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Yifeng Pharmacy Chain had revenue of CNY 23.92 billion and earned 1.52 billion in profits. Earnings per share was 1.26.
| Revenue | 23.92B |
| Gross Profit | 9.23B |
| Operating Income | 2.15B |
| Pretax Income | 2.15B |
| Net Income | 1.52B |
| EBITDA | 2.36B |
| EBIT | 2.15B |
| Earnings Per Share (EPS) | 1.26 |
Balance Sheet
The company has 8.06 billion in cash and 5.55 billion in debt, giving a net cash position of 2.51 billion or 2.07 per share.
| Cash & Cash Equivalents | 8.06B |
| Total Debt | 5.55B |
| Net Cash | 2.51B |
| Net Cash Per Share | 2.07 |
| Equity (Book Value) | 10.90B |
| Book Value Per Share | 8.46 |
| Working Capital | 2.39B |
Cash Flow
In the last 12 months, operating cash flow was 5.08 billion and capital expenditures -796.24 million, giving a free cash flow of 4.29 billion.
| Operating Cash Flow | 5.08B |
| Capital Expenditures | -796.24M |
| Free Cash Flow | 4.29B |
| FCF Per Share | 3.54 |
Margins
Gross margin is 38.59%, with operating and profit margins of 9.00% and 6.37%.
| Gross Margin | 38.59% |
| Operating Margin | 9.00% |
| Pretax Margin | 8.99% |
| Profit Margin | 6.37% |
| EBITDA Margin | 9.87% |
| EBIT Margin | 9.00% |
| FCF Margin | 17.92% |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 2.01%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 2.01% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 35.04% |
| Buyback Yield | -1.00% |
| Shareholder Yield | 1.01% |
| Earnings Yield | 5.07% |
| FCF Yield | 14.26% |
Stock Splits
The last stock split was on June 7, 2024. It was a forward split with a ratio of 1.2.
| Last Split Date | Jun 7, 2024 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
Yifeng Pharmacy Chain has an Altman Z-Score of 2.83. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.83 |
| Piotroski F-Score | n/a |